<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc. (NASDAQ:MRNA) shares were trading higher Monday, likely after the company announced a supply agreement with Argentina for 20 million doses of its COVID-19 vaccine. The company said if authorized, it would begin delivery in the first quarter of 2022.
...read full article on Benzinga
